Hypofractionated Stereotactic Re-irradiation and
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Pouessel D, Ken S, Gouaze-Andersson V, Piram L, Mervoyer A, Larrieu-Ciron D, Cabarrou B, Lusque A, Robert M, Frenel JS, Uro-Coste E, Olivier P, Mounier M, Sabatini U, Sanchez EH, Zouitine M, Berjaoui A, Cohen-Jonathan Moyal E.
Pouessel D, et al. Among authors: berjaoui a.
Oncologist. 2023 Sep 7;28(9):825-e817. doi: 10.1093/oncolo/oyad095.
Oncologist. 2023.
PMID: 37196069
Free PMC article.
Clinical Trial.